Susquehanna Portfolio Strategies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-154,720
Closed -$9.09M 997
2023
Q4
$9.09M Buy
+154,720
New +$9.09M 0.16% 185